Giovanni V.
- Country
- Italy
- Department
- U.O.C. Neonatologia
Research Overview
- Efficacy and Safety of ELGN-2112 in Treating Intestinal Malabsorption in Preterm Infants: A Double-Blind, Randomized, Placebo-Controlled Study
- Phase I single arm, dose escalating and phase II double blind, randomized, placebo-controlled dose finding clinical trial assessing safety, and efficacy of intratracheal administration of allogeneic umbilical mesenchymal cells-derived extracellular vesicles in preventing bronchopulmonary dysplasia in extremely preterm newborns.
Data & Insights
Has run more than one trial at 3 of 30 partner sites.
Specializations
Neonatal Medicine
The investigator specializes in treating extremely preterm newborns, with particular focus on bronchopulmonary dysplasia (BPD), a serious respiratory condition affecting premature infants.
- Respiratory Care in Neonates
- Preterm Birth Complications
- Neonatal Intensive Care
Their work involves advanced therapeutic approaches for protecting vulnerable newborn lungs.
Regenerative Medicine
The investigator explores innovative therapeutic applications of mesenchymal-derived extracellular vesicles in neonatal care, focusing on their potential protective effects in premature infant lung development.
- Cell-Free Therapy
- Biological Drug Development
- Intratracheal Administration
Their research encompasses novel biological approaches to preventing lung injury in preterm infants.
Preventive Medicine
The investigator focuses on developing preventive strategies for respiratory complications in premature newborns, with emphasis on early intervention approaches.
- Prevention of Lung Disease
- Risk Assessment
- Therapeutic Innovation
Their work aims to improve outcomes for extremely preterm infants through preventive therapeutic interventions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.